Full Text View
Tabular View
Study Results
Related Studies
Varenicline for the Treatment of Smokeless Tobacco (CHANCHEW)
This study has been completed.
Study NCT00813917   Information provided by Mayo Clinic

First Received on December 22, 2008.   Last Updated on July 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nicotine Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
varenicline
placebo
Additional drug interventions recognized in this trial
Lobeline
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services